161 related articles for article (PubMed ID: 14261022)
21. General ideas concerning a vaccine against leprosy: a basis for discussion during the Eleventh International Leprosy Congress.
Convit J; Ulrich M
Int J Lepr Other Mycobact Dis; 1978; 46(1):61-3. PubMed ID: 348611
[No Abstract] [Full Text] [Related]
22. ACTIVITY OF ANTITUBERCULOSIS DRUGS AGAINST MYCOBACTERIUM LEPRAE.
SHEPARD CC; CHANG YT
Int J Lepr; 1964; 32():260-71. PubMed ID: 14227399
[No Abstract] [Full Text] [Related]
23. Interstrain variations of resistance and delayed type hypersensitivity in mice after infection with various substrains of Mycobacterium bovis (strains BCG) and after immunization with Mycobacterium leprae.
Lagrange PH
Trop Med Parasitol; 1990 Sep; 41(3):304-6. PubMed ID: 2255850
[No Abstract] [Full Text] [Related]
24. Serological response in leprosy and tuberculosis patients to the 18-kDa antigen of Mycobacterium leprae and antigen 85B of Mycobacterium bovis BCG.
Vikerfors T; Olcén P; Wiker H; Watson JD
Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):571-80. PubMed ID: 8151188
[TBL] [Abstract][Full Text] [Related]
25. Vaccination against leprosy--the view from 1996.
Fine PE; Smith PG
Lepr Rev; 1996 Dec; 67(4):249-52. PubMed ID: 9033195
[No Abstract] [Full Text] [Related]
26. Cell walls from Mycobacterium tuberculosis (BCG) as vaccine against Mycobacterium leprae infections in mice.
Shepard CC; Ribi E
Proc Soc Exp Biol Med; 1968 Feb; 127(2):517-21. PubMed ID: 4967027
[No Abstract] [Full Text] [Related]
27. Anti-leprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: lepromin skin test results.
Gormus BJ; Baskin GB; Xu K; Ratterree MS; Mack PA; Bohm RP; Meyers WM; Walsh GP
Lepr Rev; 2002 Sep; 73(3):254-61. PubMed ID: 12449891
[TBL] [Abstract][Full Text] [Related]
28. Effects of vaccination with several mycobacterial proteins and lipoproteins on Mycobacterium leprae infection of the mouse.
Ngamying M; Varachit P; Phaknilrat P; Levy L; Brennan PJ; Cho SN
Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):43-5. PubMed ID: 11480318
[No Abstract] [Full Text] [Related]
29. [CHANGES IN THE LEVEL OF PROTEIN FRACTIONS IN VACCINATED AND TUBERCULOSIS-INFECTED GUINEA PIGS].
BREZINA O
Bratisl Lek Listy; 1964; 44():499-506. PubMed ID: 14147729
[No Abstract] [Full Text] [Related]
30. [Vaccination against leprosy].
Lechat MF
Ann Soc Belg Med Trop; 1982; 62(3):179-82. PubMed ID: 6758711
[No Abstract] [Full Text] [Related]
31. Comparison of various preparations of Mycobacterium leprae and other mycobacteria by lymphocyte stimulation.
Bjune G
Int J Lepr Other Mycobact Dis; 1978; 46(3-4):386-93. PubMed ID: 83309
[TBL] [Abstract][Full Text] [Related]
32. Cross-reactivity of Mycobacterium leprae and M. tuberculosis and the implications for assessment of in vitro T cell function in leprosy patients.
Rawlinson WD; Basten A
Trans R Soc Trop Med Hyg; 1989; 83(4):557-9. PubMed ID: 2482558
[TBL] [Abstract][Full Text] [Related]
33. In the footsteps of Albert Calmette: an ecological study of TB, leprosy and potential exposure to wild-type Mycobacterium bovis.
Pépin J; Fox A; LeBlanc L; De Wals P; Rousseau MC
Trans R Soc Trop Med Hyg; 2022 Dec; 116(12):1112-1122. PubMed ID: 35460554
[TBL] [Abstract][Full Text] [Related]
34. Antigens of Mycobacterium leprae identified by immunoprecipitation with sera from leprosy and tuberculosis patients.
Britton WJ; Hellqvist L; Garsia RJ; Basten A
Clin Exp Immunol; 1988 Mar; 71(3):394-8. PubMed ID: 3289801
[TBL] [Abstract][Full Text] [Related]
35. Animal vaccination studies with Mycobacterium leprae.
Shepard CC
Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):519-23. PubMed ID: 6368416
[No Abstract] [Full Text] [Related]
36. Epidemiological considerations in vaccine trials in leprosy.
Noordeen SK
Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):556-8. PubMed ID: 6368420
[No Abstract] [Full Text] [Related]
37. Advances and hurdles on the way toward a leprosy vaccine.
Duthie MS; Gillis TP; Reed SG
Hum Vaccin; 2011 Nov; 7(11):1172-83. PubMed ID: 22048122
[TBL] [Abstract][Full Text] [Related]
38. IMMUNOLOGIC STUDIES WITH MYCOBACTERIUM LEPRAE AND AN ACID-FAST MYCOBACTERIUM CULTIVATED FROM HUMAN LEPROSY NODULES.
RAO SS; NADKARNI JS; KHANOLKAR VR
Int J Lepr; 1964; 32():103-16. PubMed ID: 14203318
[No Abstract] [Full Text] [Related]
39. Vaccines against leprosy.
Gupte MD
Indian J Lepr; 1991; 63(3-4):342-9. PubMed ID: 1804888
[No Abstract] [Full Text] [Related]
40. LEPROSY TODAY.
EDWARDS RH
Lepr Rev; 1964 Jan; 35():3-13. PubMed ID: 14114050
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
